MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
DEBATE: What Does the Current Evidence on EVAR for Ruptured AAA Tell Us?
Robert J. Hinchliffe, MD, FRCS, and Janet T. Powell, MD, PhD, FRCPath, compare perspectives with Frank J. Veith. MD, and Caron B. Rockman, MD.
Thoracic Aortic Aneurysms: At What Size Should We Intervene?
Key factors to consider when selecting patients for TAA repair.
By Robert J. Hinchliffe, MD, FRCS, and Paul Hollering
Is TEVAR Safe Enough?
Weighing the risk of rupture and the benefits of treating thoracic aortic aneurysms < 6 cm.
By Benjamin O. Patterson, PhD, MRCS, and Robert J. Hinchliffe, MD, FRCS
Examining EVAR's Role in Rupture Care
By Frank R. Arko III, MD, and Matt Thompson, MD, FRCS
IMPROVE Study Compares EVAR-First Strategy Versus Open Repair for Ruptured AAAs
April 16, 2015—One-year outcomes in the IMPROVE trial were published by Richard Grieve, MD, et al online ahead of print in the European Heart Journal.
TEVAR: Advances and Remaining Questions
By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS, Guest Chief Medical Editors
Hypogastric Artery Embolization and Endografting
Controversies and techniques on the prevention and treatment of endoleaks.
By Robert J. Rosen, MD, and Richard M. Green, MD
